Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sandra, Vorlová"'
Publikováno v:
Angewandte Chemie; September 2, 2002, Vol. 114 Issue: 17 p3338-3341, 4p
Publikováno v:
Angewandte Chemie; September 2, 2002, Vol. 114 Issue: 17 p3338-3341, 4p
Publikováno v:
Angewandte Chemie. International Edition; September 2, 2002, Vol. 41 Issue: 17 p3211-3213, 3p
Publikováno v:
Angewandte Chemie. International Edition; September 2, 2002, Vol. 41 Issue: 17 p3211-3213, 3p
Autor:
Sandra Vorlová, Simona Veitl, Anja E Kuhn, Ster Irmak, Berin Upcin, Sabine Herterich, Matthias Kallius, Leonie Rossow, Daniela Scheld, Jacqueline K. Wax, Franziska Karl, Verena Maltzahn, Erik Henke, H. Hoffmann, Sabine Gätzner, Süleyman Ergün, Rajender Nandigama, Alma Zernecke
Publikováno v:
Oncogene
The potential of altering the tumor ECM to improve drug response remains fairly unexplored. To identify targets for modification of the ECM aiming to improve drug response and overcome resistance, we analyzed expression data sets from pre-treatment p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afbc94ce71329763c420d3928b126f25
https://doi.org/10.1038/s41388-018-0320-2
https://doi.org/10.1038/s41388-018-0320-2
Autor:
Sandra Vorlová, Massimo Squatrito, Eric C. Holland, Ying-Xian Pan, Luca Cartegni, Gina Rocco, Clare V. Lefave, Cameron Brennan
Publikováno v:
The EMBO Journal. 30:4084-4097
In tumours, aberrant splicing generates variants that contribute to multiple aspects of tumour establishment, progression and maintenance. We show that in glioblastoma multiforme (GBM) specimens, death‐domain adaptor protein Insuloma‐Glucagonoma
Autor:
Gina Rocco, Sandra Vorlová, Ken C. Hess, Erik Henke, Michelle L. Hastings, Francine M. Jodelka, Luca Cartegni, Clare V. Lefave
Publikováno v:
Molecular Cell. 43(6):927-939
Alternative intronic polyadenylation (IPA) can generate truncated protein isoforms with significantly altered functions. Here, we describe 31 dominant-negative, secreted variant isoforms of receptor tyrosine kinases (RTKs) that are produced by activa
Autor:
Friedrich Schütze, Sandra Vorlová, Süleyman Ergün, Sabine Gätzner, Erik Henke, Florian Röhrig, Anja E Kuhn
Publikováno v:
Scientific Reports
Tumors are characterized by a rigid, highly cross-linked extracellular matrix (ECM), which impedes homogeneous drug distribution and potentially protects malignant cells from exposure to therapeutics. Lysyl oxidases are major contributors to tissue s
Autor:
Andreas Rosenwald, Sandra Vorlová, Florian Röhrig, Erik Henke, David A. Scheinberg, H. Hoffmann, Sabine Gätzner, Isabel Weigand, Zvi Granot, Martin Wartenberg, Olaf Penack, Freddy E. Escorcia, Süleyman Ergün, S Keller, M Tenspolde, Katia Manova
Publikováno v:
Oncogene
Röhrig, F; Vorlová, S; Hoffmann, H; Wartenberg, Martin; Escorcia, F E; Keller, S; Tenspolde, M; Weigand, I; Gätzner, S; Manova, K; Penack, O; Scheinberg, D A; Rosenwald, A; Ergün, S; Granot, Z; Henke, E (2016). VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors. Oncogene, 36(1), pp. 1-12. Nature Publishing Group 10.1038/onc.2016.182
Röhrig, F; Vorlová, S; Hoffmann, H; Wartenberg, Martin; Escorcia, F E; Keller, S; Tenspolde, M; Weigand, I; Gätzner, S; Manova, K; Penack, O; Scheinberg, D A; Rosenwald, A; Ergün, S; Granot, Z; Henke, E (2016). VEGF-ablation therapy reduces drug delivery and therapeutic response in ECM-dense tumors. Oncogene, 36(1), pp. 1-12. Nature Publishing Group 10.1038/onc.2016.182
The inadequate transport of drugs into the tumor tissue caused by its abnormal vasculature is a major obstacle to the treatment of cancer. Anti-vascular endothelial growth factor (anti-VEGF) drugs can cause phenotypic alteration and maturation of the
Publikováno v:
Biotechnology and bioengineering. 80(5)
In a previous report, Morel and Massoulié showed that Bungarus AChE (bBAChE) is produced more efficiently than rat AChE in various expression systems, mainly because the Bungarus coding sequence exerts a stimulatory effect on transcription (Morel an